Hypoglycemic effects of aqueous extract of juglans regia in type 2 diabetic patients
Phase 3
- Conditions
- Type II diabetes mellitus.Endocrine and Metabolid Diseases
- Registration Number
- IRCT138803061957N1
- Lead Sponsor
- Research Institute For Islamic and Complementary Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Type 2 diabetic patients receiving oral anti-diabetic medications with FBS 140-250
Exclusion criteria:
insulin therapy, liver or kidney diseases, pregnancy, breast feeding.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Sugar. Timepoint: Before and After intervention. Method of measurement: Biochemistry Lab test.
- Secondary Outcome Measures
Name Time Method 2 Hr Post Prandial Glucose. Timepoint: Before and after intervention. Method of measurement: Biochemistry lab test.;HbA1c. Timepoint: Before and after intervention. Method of measurement: Blood chromatography.